Analytical Data
-
Gene name
IVD
- Application
-
Alternative Names
IVD;Isovaleryl-CoA dehydrogenase. mitochondrial
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P26440
-
Expression Region
30-423aa
-
AA Sequence
H SLLPVDDAIN GLSEEQRQLR QTMAKFLQEH LAPKAQEIDR SNEFKNLREF WKQLGNLGVL GITAPVQYGG SGLGYLEHVL VMEEISRASG AVGLSYGAHS NLCINQLVRN GNEAQKEKYL PKLISGEYIG ALAMSEPNAG SDVVSMKLKA EKKGNHYILN GNKFWITNGP DADVLIVYAK TDLAAVPASR GITAFIVEKG MPGFSTSKKL DKLGMRGSNT CELIFEDCKI PAANILGHEN KGVYVLMSGL DLERLVLAGG PLGLMQAVLD HTIPYLHVRE AFGQKIGHFQ LMQGKMADMY TRLMACRQYV YNVAKACDEG HCTAKDCAGV ILYSAECATQ VALDGIQCFG GNGYINDFPM GRFLRDAKLY EIGAGTSEVR RLVIGRAFNA DFH
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
In recent years, the field of in vitro diagnostics (IVD) has witnessed remarkable advancements, particularly in the development and application of recombinant proteins. These proteins, produced through recombinant DNA technology, play a crucial role in enhancing the sensitivity and specificity of diagnostic tests. As disease prevalence rises globally, the demand for accurate and rapid diagnostic tools has surged, especially in areas such as infectious diseases, autoimmune disorders, and oncology. Recombinant proteins serve as pivotal antigens or antibodies in various assays, including enzyme-linked immunosorbent assays (ELISA), Western blotting, and molecular diagnostics. The ability to produce large quantities of highly pure and specific proteins has significantly improved test performance, addressing the limitations of traditional diagnostic methods that often rely on native proteins derived from human or animal sources. Moreover, recombinant proteins can facilitate standardization across laboratories and increase the reproducibility of results, which is essential for ensuring quality control in IVD products. The ongoing research in this area focuses on optimizing expression systems, enhancing protein stability, and developing innovative assay formats to meet the evolving demands of the clinical diagnostic landscape. As a result, recombinant proteins are becoming integral to the next generation of IVD products, contributing to early disease detection, monitoring, and personalized medicine, ultimately improving patient outcomes and public health.
